News
Piramal Pharma reports consolidated net loss of Rs 81.70 crore in the June 2025 quarter
29-Jul-2025 | 07:36
Sales decline 0.89% to Rs 1933.71 crore
Net Loss of Piramal Pharma reported to Rs 81.70 crore in the quarter ended June 2025 as against net loss of Rs 88.64 crore during the previous quarter ended June 2024. Sales declined 0.89% to Rs 1933.71 crore in the quarter ended June 2025 as against Rs 1951.14 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 1933.71 | 1951.14 | -1 |
| OPM % | 5.52 | 10.48 | - |
| PBDT | 97.52 | 139.47 | -30 |
| PBT | -99.76 | -45.08 | -121 |
| NP | -81.70 | -88.64 | 8 |
Powered by Capital Market - Live News